...
首页> 外文期刊>JEMDSA: Journal of Endocrinology, Metabolism and Diabetes of South Africa (JEMSDA) : The Official Journal of the Society of Endocrinology, Metabolism, and Diabetes of South Africa >Characteristics and outcome of patients with pheochromocytoma at a tertiary endocrinology clinic in Durban, South Africa over 14 years
【24h】

Characteristics and outcome of patients with pheochromocytoma at a tertiary endocrinology clinic in Durban, South Africa over 14 years

机译:南非德班三级内分泌科诊所的嗜铬细胞瘤患者的特征和预后超过14年

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Abstract Objectives : To evaluate the characteristics and outcomes of treatment of patients with pheochromocytoma at Inkosi Albert Luthuli Central Hospital (ILACH) in Durban, South Africa over 14 years. Design : Retrospective chart review. Setting and subjects : Patients with pheochromocytoma attending the endocrinology clinic at IALCH between 2012 and 2016 were studied. Outcome measures : Clinical, biochemical and radiological data were collected at presentation, on discharge, one year and five years after surgical intervention; tumour characteristics, histopathological features and surgical outcome were also assessed. Results : The analysis included 35 patients (mean age 33.2 ± 15.7 years; 60% female). Headache (68.6%), palpitation (60%) and sweating (57.6%) were the three most common presenting symptoms; hypertension was the predominant clinical finding (85.7%). Most pheochromocytomas were sporadic (82.9%), adrenal gland tumours (68.6%) and benign (77.1%); of eight patients with malignant tumours, two were familial. Adrenalectomy was undertaken in the majority (n = 34; 97.1%); 55.2% were large tumours. The use of adjunctive radiotherapy (n = 4; 11.4%) and chemotherapy (n = 1; 2.9%) was low. There was low overall mortality (5.7%), but 57.6% developed intraoperative hypotension. At one year postoperatively, 80% (n = 28) of patients were defined as cure, biochemically in 23 (82.1%) and with radiology in five (17.9%). Conclusions : Most patients presenting to IALCH had large intra-abdominal tumours with high cure rate, low mortality but a high rate of perioperative complications. Late presentation and large tumour size was a feature.
机译:摘要目的:评估南非德班因科西阿尔伯特·鲁特利中央医院(ILACH)长达14年的嗜铬细胞瘤患者的特征和治疗效果。设计:回顾性图表审查。研究对象:2012年至2016年间在IALCH内分泌科就诊的嗜铬细胞瘤患者。结果措施:在就诊时,出院时,手术后一年和五年时收集临床,生化和放射学数据;还评估了肿瘤特征,组织病理学特征和手术结果。结果:分析包括35例患者(平均年龄33.2±15.7岁;女性占60%)。头痛(68.6%),心慌(60%)和出汗(57.6%)是最常见的三种症状。高血压是主要的临床发现(85.7%)。大部分嗜铬细胞瘤为散发性(82.9%),肾上腺肿瘤(68.6%)和良性(77.1%);在八名恶性肿瘤患者中,有两名是家族性的。大多数患者进行了肾上腺切除术(n = 34; 97.1%); 55.2%是大肿瘤。辅助放疗(n = 4; 11.4%)和化学疗法(n = 1; 2.9%)的使用率很低。总死亡率较低(5.7%),但术中低血压发生率为57.6%。术后一年,将80%(n = 28)的患者定义为治愈,其中23例(82.1%)的患者进行了生化检查,其中五例(17.9%)接受了放射学检查。结论:大多数接受IALCH治疗的患者腹腔内肿瘤较大,治愈率高,死亡率低,围手术期并发症发生率高。表现晚,肿瘤大是特征。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号